𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma

✍ Scribed by Peter E. Clark; M.Craig Hall; Antonius Miller; Kevin P. Ridenhour; Diana Stindt; James F. Lovato; Suzanne E. Patton; William Brinkley; Sarab Das; Frank M. Torti

Book ID
116944164
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
114 KB
Volume
63
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pilot trial of bone-targeted therapy wit
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-Ξ³ for metastatic renal cell carcinoma
✍ Nizar Tannir; Eric Jonasch; Lance C. Pagliaro; Paul Mathew; Arlene Siefker-Radtk πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 482 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The purpose of the study was to evaluate the efficacy and safety of a bone‐targeted regimen consisting of zoledronate, thalidomide, and interferon‐γ in patients with renal cell carcinoma and bone metastases. ## METHODS. Eligible patients had radiographic evidence of bo